Listar por autor "Rojo-Martínez, Gemma"
Mostrando ítems 1-8 de 8
-
A proposal of a mixed diagnostic system based on decision trees and probabilistic experts rules
Aguilera-Venegas, Gabriel
; Roanes-Lozano, Eugenio; Rojo-Martínez, Gemma; Galán-García, José Luis (2023)
Decision trees and rule-based expert systems (RBES) are standard diagnostic tools. We propose a mixed technique that starts with a probabilistic decision tree where information is obtained from a real world data base. The ... -
Association between exposure to air pollution and blood lipids in the general population of Spain.
Valdés Hernández, Sergio; Doulatram-Gamgaram, Viyey; Maldonado Araque, Cristina; García-Escobar, Eva; García Serrano, Sara; Oualla-Bachiri, Wasima; García- Vivanco, Marta; Garrido, Juan Luis; Gil, Victoria; Martín-Llorente, Fernando; Calle-Pascual, Alfonso; Castaño, Luís; Delgado, Elías; Menéndez, Edelmiro; Franch-Nadal, Josep; Gaztambide, Sonia; Girbés, Joan; Chaves, F. Javier; Galán-García, José L.; Aguilera-Venegas, Gabriel; Vallvé, Joan Carles; Amigó, Nuria; Guardiola, Montse; Ribalta, Josep; Rojo-Martínez, Gemma[et al.] (Wiley, 2023-09-23)
Background and Aims: We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein measures, in a nationwide sample representative of the adult population of Spain.Methods: ... -
Comparing and Tuning Machine Learning Algorithms to Predict Type 2 Diabetes Mellitus
Aguilera-Venegas, Gabriel; López-Molina, Amador; Galán-García, José Luis; Rojo-Martínez, Gemma (2022-06-13)
The main goals of this work is to study and compare machine learning algorithms to predict the development of type 2 diabetes mellitus. Four classifi cation algorithms have been considered, studying and comparing the ... -
Comparing and Tuning Machine Learning Algorithms to Predict Type 2 Diabetes Mellitus
Aguilera-Venegas, Gabriel; López-Molina, Amador; Rojo-Martínez, Gemma; Galán-García, José Luis (Elsevier, 2023)
The main goals of this work are to study and compare machine learning algorithms to predict the development of type 2 diabetes mellitus. Four classification algorithms have been considered, studying and comparing the ... -
Epigenetic changes in the metabolically healthy obese: A case-control versus a prospective study
(Wiley, 2022-03-28)Obesity has become a worldwide health problem, in which latest statistics reported an increased trend over the last years. Accordingly, long-term obesity is involved in an increased risk of developing several metabolic ... -
Evaluación del metabolismo hidrocarbonado y riesgo de diabetes en sujetos hospitalizados por cardiopatía isquémica
(Universidad de Málaga, Servicio de Publicaciones y Divulgación Científica, 2014)Este trabajo forma parte de un proyecto de evaluación clínica global de los pacientes hospitalizados en una planta de Cardiología del Hospital Regional de Málaga, y consta de dos partes: 1ª parte. Estudio transversal ... -
Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study
Ruiz-García, Ignacio; Ortiz-Flores, Rodolfo; Badía, Rocío; García-Borrego, Aranzazu; García-Fernández, María Inmaculada; Lara, Estrella; Martín-Montáñez, Elisa; García Serrano, Sara; Valdés, Sergio; Gonzalo, Montserrat; Tapia Guerrero, María José; Fernández-García, José Carlos; Sánchez-García, Alicia; Muñoz-Cobos, Francisca; Calderón-Cid, Miguel; El-Bekay, Rajaa; Covas, María-Isabel; Rojo-Martínez, Gemma; Olveira-Fuster, Gabriel María; Romero-Zerbo, Silvana Yanina; Bermúdez Silva, Francisco Javier[et al.] (Elsevier, 2023)
Background: Oleocanthal and oleacein are olive oil phenolic compounds with well known anti inflammatory and anti-oxidant properties. The main evidence, however, is provided by experimental studies. Few human studies have ... -
Sistemas de infusión subcutánea continua de insulina en personas con diabetes tipo 1. Una experiencia biopsicosocial
(Servicio de Publicaciones y Divulgacion Cientifica, 2015)El tratamiento intensivo insulínico reduce el riesgo de complicaciones en las personas con DM1 y es el tratamiento de elección desde el diagnóstico de la enfermedad utilizando múltiples dosis de insulina (MDI) o mediante ...